Sable Offshore Corp. heads into its May 14 earnings call carrying the double weight of a highly shorted float and a cluster of fresh insider selling — a combination that makes the next print unusually charged.
The insider story is the sharpest signal this week. On April 29, Founder and CEO James Flores sold 68,792 shares at $13.56, pocketing roughly $933,000. CFO Gregory Patrinely and General Counsel Anthony Duenner each offloaded another 39,000-plus shares the same day. Flores had sold again the day before. Each of those transactions coincided with equity awards — the executives received new stock grants at the same time — but the net effect is clear: the people closest to the business were trimming exposure at prices well below where Street targets cluster. Over the rolling 90 days the insider ledger nets to a positive 1.2 million shares, but that figure is distorted by the awards themselves. The cash-sales picture tells a more cautious story.
Short positioning is deep, though it has been easing at the margin. Short interest runs at roughly 19.7% of the free float — an elevated level for any single-asset E&P name — yet that figure is down about 8% from a month ago when it was closer to 21%. The retreat mirrors the stock's sharp move off its April lows: SOC gained 8.5% on the week, recovering to $14.26. As shorts covered into the price recovery, the ORTEX short score remained pinned near 73, ranking in the bottom 3rd percentile of the universe on short positioning — meaning almost every other stock has less short pressure. Days to cover remain above six, and the FINRA-reported figure of 28.2 million shares on a mid-April settlement date confirms the depth of the position. Borrow availability has loosened slightly as some shorts closed out, though cost to borrow nudged up 21% on the week to 0.83% — still cheap in absolute terms, but directionally higher as the earnings date closes in.
Options traders are positioned firmly on the bullish side, and the tilt is becoming more extreme. The put/call ratio has compressed to 0.32, sitting about 1.35 standard deviations below its 20-day mean of 0.37. That's a meaningfully skewed call-heavy setup, running near the lower end of the past year's range — a 52-week low of 0.18 gives the floor. The move away from puts has been consistent: through March and early April the PCR ran closer to 0.42-0.45; it has drifted lower every week since. Call buyers are dominating the options market even as short sellers maintain a large aggregate position, a divergence that rarely resolves quietly.
What the Street thinks is harder to read cleanly given the churn in targets. Jefferies' Lloyd Byrne — the most recent action, reported April 22 — maintained a Buy but cut his target from $30 to $24, bringing it closer to the current price after an earlier March raise. Benchmark downgraded to Hold in early March without publishing a new target. The mean target across active coverage is $27, implying roughly 89% upside from current levels, but that gap reflects how far the stock has fallen from the $30-plus territory it briefly occupied in early 2025 rather than any fresh bullish conviction. The EV/EBITDA multiple of 5.1x has compressed roughly 8% over the past month, and the PE of 6.8x screens cheaply — though for a single-basin oil producer exposed to commodity prices and a concentrated regulatory risk, multiples alone do not tell the whole story. EPS momentum over the past 30 days ranks in the 96th percentile of the universe, a striking contrast with the 90-day reading at the 1st percentile, signalling how abruptly the near-term earnings picture has shifted.
Ownership concentration adds texture to the risk profile. Pilgrim Global Advisors holds 12.4% of shares and added over 8 million shares in the December quarter. Capital Research built a 7.9% stake, adding nearly 9.8 million shares in the same period. Alyeska came in with 10.4 million new shares. These are not passive index positions — they are active managers who built or materially grew stakes in the back half of 2025, largely at prices well above the current $14 handle. Their willingness to hold, or add, into an earnings release that has previously moved the stock by as much as 35% in a single session (November 2025, down) and 82% over five days (the February 2026 print) will be the most consequential positioning question of the coming week.
The earnings history is the starkest data point of all. The last four events produced a +4.5%, +8.7%, -7.4%, and -34.5% one-day move respectively. Two of those were unscheduled announcements rather than formal quarterly calls. The next event on May 14 is formal and pre-announced, but given the variance in prior reactions and the current setup — heavily shorted float, CEO selling, call-heavy options, a freshly compressed valuation — the range of outcomes is wide. What to watch is whether the company offers any update on production ramp progress at the Santa Ynez Unit and how it addresses the debt refinancing picture, which remains the central fault line between the bull and bear cases.
See the live data behind this article on ORTEX.
Open SOC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
